You just read:

Myovant Sciences Announces Presentation of Data at the European Congress of Endocrinology from Phase 2 Extension Study Evaluating Relugolix in Women with Endometriosis-Associated Pain

News provided by

Myovant Sciences

24 May, 2017, 08:00 ET